Genomic & Biopharma News

Testa Analytical offers new UV detector for high temperature applications
Testa Analytical Solutions e.K reports on its development of a unique high temperature UV detector for a leading European polymer research center.
News Medical Life Sciences, 2020-02-21 15:44:39

Sun Sentinel: Ocean Ridge Biosciences expands to 5,400-square foot facility
Ocean Ridge Biosciences is a survivor in South Florida's fledgling biotech industry. In the past decade, Ocean Ridge has worked with more than 200 academic labs and companies, providing gene-based lab analysis of blood and tissue samples for the development of new drugs and diagnostic tests. Please read the PDF for more details
ORB Company News, 2016-12-28 18:58:47

Struggling Tocagen becomes Nasdaq on-ramp for Forte Bio
Last fall, a late-stage brain cancer flop prompted Tocagen to cut 65% of its workforce to stay afloat. Now, out of options, the one-time cancer specialist will become Forte Biosciences’ route to the public markets. The duo announced Wednesday that they would merge in an all-stock deal.
Fierce Biotech, 2020-02-21 15:07:05

Sophia Genetics taps ex-Foundation Medicine CEO as chairman
The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics after serving on its board of directors for less than a year.
Fierce Biotech, 2020-02-21 14:59:28

Gilead loses again in PrEP patent fight with HHS, sending dispute to federal court
For the second time this month, Gilead has suffered a setback in its public patent dispute with the U.S. government. A patient review board decided against striking up a review of HHS patents on HIV prevention drug Truvada after Gilead argued they were invalid.
Fierce Pharma, 2020-02-21 14:20:43

Allergan's Botox still a physician favorite for migraine despite CGRP push: analyst
With CGRP drugs on the rise in the preventive migraine market, old stalwarts like Allergan's Botox are feeling the pinch from the new competition. But a new survey says neurologists may not be so quick to give up on Botox––and that could be another win for AbbVie on the eve of its Allergan merger.
Fierce Pharma, 2020-02-21 13:54:15

Opdivo-Yervoy Combo Showing Durable Benefits in Untreated Kidney Cancers in Long-term Trial

Immuno-Oncology News, 2020-02-21 13:00:20

Effector co-founder leaves to take up CSO post at Turning Point
Siegfried Reich has ended his seven-year involvement with Effector Therapeutics. Reich co-founded Effector and served as its senior vice president of research but has moved on to take up the chief scientific officer position at Turning Point Therapeutics.
Fierce Biotech, 2020-02-21 12:42:33

FiercePharmaAsia—Coronavirus's impact on AstraZeneca, global drug supply; vadadustat PRV
AstraZeneca braces for COVID-19's impact on its China business as global health regulators monitor for potential disruptions in drug supplies. Akebia Therapeutics will use a priority review voucher on the application for its Otsuka-partnered anemia drug vadadustat. And more.
Fierce Pharma, 2020-02-21 12:34:17

Harnessing the microbiome potential
Spring is underway in parts of the US, and while Florida by no means undergoes the dramatic reappearance of foliage or colorful clumps of daffodils and azaleas, the southern part of the sunshine state experiences its share of spring renewals.  For instance, recently a brood of Muscovy duck (Cairina moschata) hatchlings appeared near Ocean Ridge Biosciences' laboratory.
ORB Company Blog, 2017-03-31 21:41:45

BioMarin gene therapy won't need an AdComm as it nabs speedy FDA review
BioMarin’s hemophilia A drug has been set an Aug. 21 PDUFA date as the California biotech looks to gain a speedy approval for the first gene therapy for the bleeding disease.
Fierce Biotech, 2020-02-21 12:29:37